Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Sale of product	$ 2,229,947	$ 1,783,047	$ 7,258,006	$ 4,377,891
Cost of product	1,454,068	1,164,187	4,563,869	2,646,430
Gross profit	775,879	618,860	2,694,137	1,731,461
Operating costs and expenses:
Salaries and contract labor	1,523,618	415,333	2,669,940	1,383,209
General, administrative and consulting	474,667	355,188	1,375,828	1,205,391
Research and development	1,239,345	1,469,027	4,238,229	3,487,997
Total operating expenses	3,237,630	2,239,548	8,283,997	6,076,597
Net operating loss	(2,461,751)	(1,620,688)	(5,589,860)	(4,345,136)
Other income (expense):
Other income (expense)	3,181	23,663	6,339	39,726
Equity in net income of affiliate	43,451	0	119,697	0
Interest income	712	865	3,989	2,579
Interest expense	(2,463,326)	(168,225)	(2,794,967)	(433,486)
Total other expense	(2,415,982)	(143,697)	(2,664,942)	(391,181)
Net loss	(4,877,733)	(1,764,385)	(8,254,802)	(4,736,317)
Less income attributable to noncontrolling interest	6,557	0	(1,572)	0
Net loss attributable to International Isotopes Inc.	$ (4,871,176)	$ (1,764,385)	$ (8,256,374)	$ (4,736,317)
Net loss per common share - basic and diluted	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)
Weighted average common shares outstanding - basic	335,249,349	293,941,928	327,291,515	293,913,991
Weighted average common shares outstanding - diluted	335,249,349	293,941,928	327,291,515	293,913,991